Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type, By Onset Time, By Products, By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin market is projected to register a robust growth during the forecast period. The growth can be attributed to the rising number of patients suffering from diabetes and growing research & development activities for drug discovery. Insulin is used to manage blood sugar levels in the body and thus reduce the symptoms of diabetes and vascular complications. According to the World Health Organization statistics, Saudi Arabia ranks seventh in the rate of diabetes. The estimates show that 7 million of the country’s population are diabetic while 3 million have pre-diabetic conditions. Increasing awareness of diabetes and advancing healthcare facilities providing treatment for chronic disorders are also propelling the growth of Saudi Arabia human insulin market. The risk of diabetes is likely to increase with growing age, and currently around 25% adults over 60 years suffer from diabetes. Thus, increasing prevalence of geriatric population is also anticipated to fuel the growth of Saudi Arabia human insulin market in the coming years. Allocation of huge funds for the healthcare, launch of new programs to educate people about diabetics by the government, and technological advancements in the field of human insulin delivery devices are likely to drive the growth of Saudi Arabia human insulin market. However, stringent regulatory requirements for the product approvals as well high manufacturing costs could restrain the growth of Saudi Arabia human insulin market. Besides, the key players are making huge investments to devise effective ways to use insulin and minimize the side-effects, which is expected to contribute to the growth of Saudi Arabia human insulin market.

The Saudi Arabia Human Insulin market is segmented on the basis of indication, route of administration, type, onset time, products, regional distribution, and company. Based on the products, the market is divided into insulin pens, insulin pumps, infusion systems, and injection. The insulin pens segment is anticipated to dominate the Saudi Arabia human insulin market due to significant reimbursements offered for human insulin pens and their continuous pipeline development & product commercialization.

Key players in Saudi Arabia human insulin market are Novo Nordisk Saudi Arabia, Sanofi Saudi Arabia, Baxter International Saudi Arabia, B Braun Saudi Arabia, Eli Lilly and Company Saudi Arabia, Pfizer Saudi Arabia, among others. Companies involved in the Saudi Arabia human insulin market are adopting competitive strategies such as partnerships, agreements, awareness campaigns, and research funding & grants to strengthen their product portfolio and sustain growth in Saudi Arabia human insulin market.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022E
• Forecast Period: 2023F-2027F

Objective of the Study:

• To analyze the historical growth in the market size of Saudi Arabia human insulin market from 2017 to 2021.
• To estimate and forecast the market size of Saudi Arabia human insulin market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast Saudi Arabia human insulin market based on indication, route of administration, type, onset time, products, regional distribution, and company.
• To identify dominant region or segment in the Saudi Arabia human insulin market.
• To identify drivers and challenges for Saudi Arabia human insulin market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Saudi Arabia human insulin market.
• To identify and analyze the profile of leading players operating in Saudi Arabia human insulin market.
• To identify key sustainable strategies adopted by market players in Saudi Arabia human insulin market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the Saudi Arabia. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers who could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the Saudi Arabia.

The publisher calculated the market size of Saudi Arabia human insulin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

• Human insulin developing companies
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to human insulin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Saudi Arabia Human Insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Saudi Arabia Human Insulin Market, By Indication:

• Type I Diabetes
• Type II Diabetes

Saudi Arabia Human Insulin Market, By Route of Administration:

• Subcutaneous
• Nasal
• Intravenous
• Transdermal
• Oral
• Others

Saudi Arabia Human Insulin Market, By Type:

• Basal
• Bolus
• Pre-mixed
• Biosimilar
• Traditional

Saudi Arabia Human Insulin Market, By Onset Time:

• Rapid Acting
• Short-Acting
• Intermediate Acting
• Long Acting
• Ultra-long Acting
• Pre-Mixed
• Inhaled

Saudi Arabia Human Insulin Market, By Products:

• Insulin Pens
• Insulin Pumps
• Infusion System
• Injection

Saudi Arabia Human Insulin Market, By Region:

• Northern & Central
• Southern
• Eastern
• Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia Human Insulin market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.